Does Express Scripts Cover Zepbound? 2026 Coverage, Prior Authorization, and Cost Guide
Published:
·Last verified: May 22, 2026·Next review: June 2026 (pricing), August 2026 (formulary)The RX Index is a pricing intelligence and comparison resource for GLP-1 telehealth providers. Affiliate disclosure: We may earn a commission if you use certain provider links on this page. Our coverage analysis is based on current public sources and is not influenced by whether a provider pays us. For your insurance research, not medical advice. Coverage and eligibility must be confirmed with your plan, your doctor, and your pharmacist before you act.
Short answer: Yes — but not the way most people assume
Does Express Scripts cover Zepbound? Yes — Express Scripts can cover Zepbound, but the answer is not the same for everyone with an Express Scripts card. Here’s the twist almost no other page mentions: in the 2026 Express Scripts National Preferred Formulary, ZEPBOUND PEN [INJ] is listed, while Zepbound Vials are listed as excluded (with Zepbound Pens, Wegovy, and liraglutide named as the preferred alternatives). Being on the formulary doesn’t guarantee your specific plan covers it — your employer or plan sponsor can still apply prior authorization, exclusions, step therapy, or a lifestyle-engagement requirement on top.
The pen vs. vial distinction is the detail that causes the most confusion. If your doctor wrote for Zepbound Vials, asking Express Scripts about “Zepbound” generically will give you the wrong answer. Ask about each formulation separately.
Important Zepbound safety basics
Per Zepbound’s FDA prescribing information: Zepbound carries a boxed warning for risk of thyroid C-cell tumors. It is contraindicated in people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, and in people with known serious hypersensitivity to tirzepatide or any Zepbound excipient. Zepbound should not be used with other tirzepatide-containing products or other GLP-1 receptor agonists. Talk to a qualified clinician before starting Zepbound.
Want to check your coverage before you start?
Ro’s free GLP-1 Insurance Coverage Checker generates a personalized coverage report on your specific plan. For enrolled Ro Body members on supported plans, Ro’s insurance concierge can submit the prior-authorization paperwork on your behalf.
Disclosure: The RX Index may earn a commission from Ro links. Coverage decisions are made by your insurer.
What’s on this page
- Your situation in one row
- What we actually verified
- Does Express Scripts cover Zepbound in 2026?
- How to check your coverage in 5 minutes
- GLP-1 programs you might be in
- Prior authorization — PA packet + timeline
- What does Zepbound cost? (3-path table)
- Does Express Scripts cover Zepbound for OSA?
- Does Express Scripts Medicare cover Zepbound?
- Does TRICARE cover Zepbound?
- What to do if your PA was denied
- What if your plan flat-out excludes Zepbound?
- Real searcher friction (Reddit examples)
- FAQ (14 questions)
Read This First: Your Situation in One Row
Pull out your insurance card and find the row that matches what you’re seeing.
| What Express Scripts says about Zepbound | What it usually means | Do this next |
|---|---|---|
| Covered | Your plan may cover it, but PA, copay, and pharmacy rules still apply | Confirm PA requirement, tier, and pharmacy channel |
| Coverage review or prior authorization required | Your doctor must send more info before the plan will pay | Send your doctor the PA packet checklist below |
| Not covered or excluded | Your plan or that formulation is not on the covered list | Ask which Zepbound formulation IS covered, or compare cash-pay paths |
| EnGuide message | GLP-1 home delivery may route through Evernorth's EnGuide Pharmacy | Ask if EnGuide is required or optional for your plan |
| Omada or Teladoc program required | Your plan added a lifestyle engagement requirement before coverage | Confirm what counts as enrollment and engagement |
| Denied | The decision is no, but the reason controls what happens next | Read the letter line by line, then use the denial map below |
What We Actually Verified for This Page
| Source | What it confirms |
|---|---|
| Express Scripts 2026 National Preferred Formulary (PDF) | ZEPBOUND PEN [INJ] listed; Wegovy injection and Wegovy tablets listed |
| Express Scripts 2026 NPF Exclusions (PDF) | Zepbound Vials excluded; preferred alternatives include Zepbound Pens, Wegovy injection, Wegovy tablets, liraglutide |
| Express Scripts coverage review / prior authorization FAQ | PA process, doctor information requirement, ~2-day turnaround after complete info |
| Evernorth Patient Assurance Program announcement | Affordability arrangements that can limit GLP-1 weight-loss copays to no more than $200/month in participating plans |
| Evernorth Prior Authorization Resources | PA pathways include EviCore, Surescripts ePA, CoverMyMeds, phone, fax, and state-specific forms |
| Eli Lilly LillyDirect Self Pay Journey Program terms | Vial and KwikPen self-pay pricing; 45-day refill condition for 7.5–15 mg |
| Lilly Zepbound savings page (zepbound.lilly.com/savings) | $25/fill commercial copay path; 2026 caps of $100/fill and $1,300/year; card expires 12/31/2026 |
| Lilly Zepbound pricing page (pricinginfo.lilly.com/zepbound) | List price ranges from $499 to $1,086.37 per fill depending on device and fill path |
| FDA Zepbound prescribing information | Indications for chronic weight management and moderate-to-severe OSA in adults with obesity; boxed warning; SURMOUNT-1 outcomes |
| CMS Medicare GLP-1 Bridge (cms.gov) | Program window, eligibility criteria, Zepbound KwikPen inclusion, $50 copay |
| TRICARE weight-loss products page (tricare.mil) | Covered TRICARE plan categories and excluded beneficiary groups |
| militaryrx.express-scripts.com | TRICARE pharmacy program rules for GLP-1s |
| AFSPA GLP-1 FAQs (afspa.org) | Foreign Service Benefit Plan EncircleRx + Teladoc Health engagement requirements |
| NYCDCC Benefit Funds 2026 notice (nyccbf.org) | NYC Carpenters plan requires Omada enrollment, four app engagements and four weigh-ins per month, and a new PA |
| Ro Pricing and GLP-1 Insurance Coverage Checker (ro.co) | Free coverage checker, membership pricing, insurance concierge for enrolled members |
If you spot anything on this page that doesn’t match a current source, email us at corrections@therxindex.com and we’ll update within 48 hours.
Does Express Scripts Cover Zepbound in 2026?
Short answer
Yes — and also not the way most people assume. ZEPBOUND PEN [INJ] is listed on the 2026 Express Scripts National Preferred Formulary. Zepbound Vials are listed as excluded on the 2026 NPF Exclusions document, with Zepbound Pens, Wegovy injection, Wegovy tablets, and liraglutide named as the preferred alternatives. Being on the formulary doesn’t guarantee your plan covers it.
Express Scripts is a pharmacy benefit manager — a PBM. It doesn’t actually sell you insurance. It runs the prescription side of someone else’s plan: your employer’s plan, a Cigna plan, a TRICARE plan, a Medicare Part D plan. Two people can both “have Express Scripts” and end up with totally different Zepbound answers because the underlying plan and the formulation on the prescription are different.
The “National Preferred Formulary” is Express Scripts’ default list. Many plans adopt it as is. Many customize it. Many add their own exclusions on top. So even when Zepbound Pen is on the National Preferred Formulary, your specific plan could still exclude weight-loss drugs entirely. And even when your plan covers Zepbound, the formulation written on the prescription matters: pen, single-dose vial, or KwikPen are not the same coverage answer in 2026.
Why pens, vials, and KwikPen are not the same coverage answer
| Formulation | 2026 Express Scripts default status | Why it matters |
|---|---|---|
| Zepbound Pen (single-dose autoinjector) | Listed on the National Preferred Formulary | The most likely covered presentation for most members |
| Zepbound Vials (single-dose vials, drawn with syringe) | Listed as excluded on the NPF Exclusions document | Plan may push you to pens, Wegovy, or liraglutide |
| Zepbound KwikPen (multi-dose pen) | Plan-specific; verify with member services | Included in the Medicare GLP-1 Bridge starting July 1, 2026 |
| Wegovy injection / Wegovy tablets | Listed | Often the "preferred alternative" if Zepbound vials are excluded |
| Liraglutide | Listed | Older GLP-1, sometimes the step-therapy requirement |
What to do with this: when you log into Express Scripts or call them, ask about each Zepbound presentation separately — not just “Zepbound.” If your doctor wrote for vials and your plan excludes vials, asking about Zepbound Pen may be the fix — but only if your specific plan covers the pen and any required PA gets approved.
Damaging admission — here on purpose
Express Scripts publishes the National Preferred Formulary as the default — your employer’s plan can override almost any line on it. We can’t tell you with 100% certainty that your plan covers Zepbound Pen. We can tell you what’s on the default list, what’s likely, and how to find out for your specific plan in under five minutes. That’s the next section.
How to Check Your Express Scripts Zepbound Coverage in 5 Minutes
Short answer
Log into the Express Scripts member portal or app, search “Zepbound,” and read the result. Then call the number on the back of your card to confirm three things: which formulation is covered, whether prior authorization is required, and whether your plan uses EnGuide, Omada, Teladoc, or a $200-cap arrangement.
Step 1 — Look on the back of your insurance card
You're looking for "Rx BIN," "Rx PCN," "Rx Group," and a member services phone number for prescription benefits. If you see "Express Scripts" or "ESI," you're in the right place.
Step 2 — Log into express-scripts.com or open the Express Scripts app
Search "Zepbound." Then search "Zepbound Pen" and "Zepbound Vial" separately. Note what each one says: covered, not covered, coverage review required, excluded, prior authorization, step therapy, quantity limit, tier number, estimated copay.
Step 3 — Screenshot everything
The drug result page. The copay estimate. Any PA, Omada, Teladoc, or EnGuide message. You'll want these on the phone call.
Step 4 — Call member services and use the exact script below
Step 5 — Write down your five answers before you hang up
The exact words to say on the call
Read this almost verbatim. Phone reps process hundreds of calls a day — they answer faster and better when you ask the right question the right way.
“Hi — I’m calling to verify plan-specific coverage for Zepbound. Could you check three formulations for me separately: Zepbound Pen, Zepbound Vial, and Zepbound KwikPen? For each one, I need to know whether it’s covered, excluded, or requires prior authorization, step therapy, quantity limits, EnGuide pharmacy, Omada, Teladoc, or another lifestyle program.”
Then ask these 10 questions in order — don’t skip any
- Is Zepbound covered under my specific plan, or only on the general Express Scripts formulary?
- Which formulation is covered for my plan — pen, vial, or KwikPen?
- Is prior authorization required? What criteria does my doctor have to document?
- Is this reviewed differently for weight management versus obstructive sleep apnea?
- Is EnGuide pharmacy required or optional for GLP-1s on my plan?
- Is Omada Health, Teladoc Health, or any lifestyle program required before the medication can ship?
- Does my plan participate in any arrangement that caps GLP-1 weight-loss copays at $200/month?
- Can I use a retail pharmacy, or do I have to use home delivery?
- What is my estimated cost before and after my deductible is met?
- If denied, what is the appeal deadline and where do I submit the appeal?
Five answers you must walk away with before you hang up
- ✅Which Zepbound formulation is covered
- ✅Whether PA is required and what your doctor needs to document
- ✅The pharmacy channel (retail, mail, EnGuide)
- ✅The estimated copay
- ✅Any lifestyle engagement requirement (Omada, Teladoc, etc.)
If your plan requires prior authorization
Many Express Scripts-administered plans do. A doctor who actually pushes the paperwork through will save you weeks. For enrolled Ro Body members on supported plans, Ro’s insurance concierge says it submits the PA on your behalf. Membership starts at $39 for the first month, then as low as $74/month with an annual plan paid upfront (otherwise $149/month ongoing).
Disclosure: The RX Index may earn a commission from Ro links.
See if Ro can submit your Zepbound prior authorization →The trade-off, plainly: Ro Body’s standard ongoing membership runs $149/month if you don’t take the annual plan. If your only goal is the cheapest possible price and you don’t need insurance help, LillyDirect direct is the cheaper move — no membership fee. Ro earns its premium when your insurance fight is the actual bottleneck.
The Express Scripts GLP-1 Programs You Might Be In
Short answer
Express Scripts and its parent Evernorth (owned by The Cigna Group) run several GLP-1 programs that can sit on top of standard pharmacy coverage. Some members are in one of them without realizing it. The ones to know are Standard NPF coverage, EncircleRx, affordability arrangements that can cap copays at no more than $200/month, EnGuide Pharmacy for home delivery, and lifestyle-engagement requirements (often Omada or Teladoc) that some plans now require for 2026.
| Program | What it is | How it affects you | Universal? |
|---|---|---|---|
| Standard NPF coverage | Zepbound Pen on the National Preferred Formulary, subject to PA and your plan's tier copay | You pay your plan's normal copay tier. The Lilly savings card can drop that to as little as $25/fill if you have commercial insurance | Default list — your specific plan can still apply exclusions or PA |
| EncircleRx | Evernorth's GLP-1 financial management program for plan sponsors, with 9 million+ enrolled lives | Your coverage may be tied to engaging with a coaching program — the specific program varies by implementation | No — plan sponsor selects EncircleRx and chooses any tied lifestyle program |
| $200/month copay arrangement | Evernorth affordability arrangements that can limit monthly out-of-pocket for Wegovy and Zepbound to no more than $200 in participating plans | If your plan participates, your maximum monthly cost is $200/month | No — only members of plans that opt in |
| EnGuide Pharmacy | Evernorth's home delivery pharmacy focused on GLP-1 dispensing | If your plan uses EnGuide, your Zepbound may have to fill there for home delivery | No — only if the plan sponsor selected EnGuide |
| Omada Health engagement requirement | Behavior-program enrollment as a condition of GLP-1 coverage. NYC Carpenters 2026 plan requires Omada enrollment, four app engagements per month, four smart-scale weigh-ins per month, and a new prior authorization | Failing engagement requirements can terminate coverage mid-year | Verified for this named example only — varies by plan |
| Teladoc Health engagement requirement | Behavior-program enrollment via Teladoc as a condition of GLP-1 coverage. AFSPA's Foreign Service Benefit Plan uses Teladoc Health and requires four weigh-ins plus four engagement activities in a rolling 30-day window | Engagement is a condition of continued coverage — same as Omada | Verified for this named example only — varies by plan |
Why this section matters more than you think
Almost every angry “Express Scripts denied my Zepbound” thread on the internet is one of these programs doing exactly what it was designed to do — the member just didn’t know it was there. If you know which program you’re in, the path forward gets simple.
Express Scripts Prior Authorization for Zepbound
Short answer
Many Express Scripts-administered plans require prior authorization for Zepbound, but the requirement is plan-specific. PA criteria commonly align with Zepbound’s FDA label: adults with obesity, or adults with overweight and at least one weight-related comorbid condition, in combination with reduced-calorie diet and increased physical activity. Express Scripts says nearly all coverage reviews are completed within two days after the doctor sends complete information.
Prior authorization is just a fancy way of saying “the plan needs more proof before they’ll pay.” It’s a checkpoint, not a denial.
Your PA Packet — what your doctor needs to send
This is the master checklist. PA criteria are plan-specific, but the list below covers what most plans ask for. Copy this and send it to your doctor’s office before they submit.
- ☐
Current BMI (measured within the last six months)
- ☐
Baseline BMI if this is a renewal (some plans deny renewals when they confuse current BMI with baseline weight at start of treatment)
- ☐
ICD-10 diagnosis code — obesity (E66.9) or overweight with comorbid condition (E66.3 plus the comorbidity code)
- ☐
Weight-related comorbidities with their own diagnosis codes if you have any (hypertension I10, dyslipidemia E78.5, type 2 diabetes E11.9, obstructive sleep apnea G47.33, cardiovascular disease)
- ☐
Weight-management history — diet attempts, exercise programs, prior weight-loss medications and outcomes
- ☐
For OSA cases: sleep study results and AHI score (apnea-hypopnea index)
- ☐
For step-therapy plans: documentation that you tried and failed (or can't take) a preferred alternative like Wegovy or liraglutide
- ☐
A statement of medical necessity that ties Zepbound to FDA-approved labeling
- ☐
The formulation you're requesting (Zepbound Pen, KwikPen, or Vial — match this to what's covered)
These criteria are FDA-label-aligned and reflect what most plans evaluate, but they are not universal Express Scripts criteria. Use your denial letter or PA form as the source of truth for your plan.
Where the PA actually gets submitted
Express Scripts and Evernorth support several PA pathways: EviCore by Evernorth (electronic PA portal), Surescripts ePA, CoverMyMeds, phone, fax, and state-specific forms. The right pathway is the one printed in your member portal, PA notice, or denial letter. Don’t guess — your doctor’s office submits to the wrong portal more often than you’d think.
How long it actually takes
Express Scripts says nearly all coverage reviews are completed within two days after the doctor sends complete information. That last part is the catch. Real cases drag on for two to four weeks — not because of insurance, but because of paperwork going back and forth.
Most common reasons PAs take longer than they should
- Missing BMI measurement
- No documented comorbidity diagnosis when BMI is between 27 and 29.9
- No documented prior weight-loss attempts
- Wrong formulation prescribed (vial instead of pen on a plan that excludes vials)
- The doctor’s office submits to the wrong PA pathway
Tired of being the messenger between your doctor and your insurance?
For enrolled Ro Body members on supported plans, Ro’s insurance concierge says the full PA process typically takes 2–3 weeks. Want to check coverage first without enrolling? Run Ro’s free GLP-1 Insurance Coverage Checker and get a free report on your plan.
Disclosure: The RX Index may earn a commission from Ro links.
What Does Zepbound Cost With Express Scripts? (The Three-Path Table)
Short answer
Your cost falls into one of three tiers. If your plan covers Zepbound Pen and you have commercial insurance, the Lilly savings card can drop your copay to as little as $25/fill (with a $100/fill cap and a $1,300 annual cap in 2026). If your plan participates in an Evernorth/Lilly affordability arrangement, your maximum is $200/month. If your plan doesn’t cover Zepbound, the lowest manufacturer self-pay path runs $299–$499/month through LillyDirect single-dose vials or KwikPen. Retail can run up to $1,086.37 per fill depending on device.
| Your situation | Monthly cost | What you need |
|---|---|---|
| Plan covers Zepbound Pen + Lilly savings card | As little as $25/fill (up to $100/fill cap, $1,300/year cap in 2026) | Commercial insurance, plan covers Zepbound, PA approved, card activated at zepbound.lilly.com |
| Plan participates in $200 affordability arrangement | Up to $200/month | Plan opted in, PA approved |
| Plan does not cover — LillyDirect Self Pay vials (28-day supply) | $299 (2.5 mg) / $399 (5 mg) / $449 (7.5–15 mg, with 45-day refill window) | Valid US prescription; cannot combine with insurance |
| Plan does not cover — Zepbound KwikPen self-pay | Starting at $299 for the KwikPen; $449 for 7.5–15 mg KwikPen with 45-day refill | Valid US prescription; verify current Lilly terms before filling |
| Plan does not cover — Zepbound single-dose pen self-pay | As low as $499 for eligible patients without coverage under Lilly's savings program | Commercial insurance without Zepbound coverage |
| Plan does not cover — branded Zepbound through Ro | $39 first month membership, then $74–$149/month ongoing, plus medication priced per Ro's published pricing | Telehealth visit + eligibility |
| Medicare GLP-1 Bridge (starting July 1, 2026) | $50/month copay | Eligible Part D enrollment, Zepbound KwikPen only, PA criteria met |
| TRICARE Prime or Select with approved PA | Standard TRICARE pharmacy copay | TRICARE-authorized prescriber, network pharmacy |
| Retail without coverage or program | List price $499 to $1,086.37 per fill | Just a prescription — almost never the right move |
The math on the savings card most pages get wrong
The Lilly Zepbound Savings Card has two limits in 2026 — most articles only mention the headline $25
- Per-fill limit: $100 (1-month) or $300 (3-month)
- Annual limit: $1,300
That means $25 only holds when your pre-card copay is $125 or less. Above that, the card covers up to $100 and you pay the rest.
| Pre-card copay | Card covers | You pay |
|---|---|---|
| $80 | $80 | $25 ✓ |
| $125 | $100 | $25 ✓ |
| $200 | $100 | $100 — not $25 |
If you hit $1,300 in card savings before the year ends, you pay your full plan copay until January 1. The card expires December 31, 2026.
Once you’ve confirmed your plan covers Zepbound, activate the savings card.
See our 2026 Zepbound Savings Card guide — we break down the four eligibility paths, what the card does and doesn’t stack with, and what changes if you switch jobs mid-year.
Does Express Scripts Cover Zepbound for Obstructive Sleep Apnea?
Short answer
Sometimes — and this is a separate coverage pathway from weight loss, not a workaround. Zepbound was FDA-approved for moderate-to-severe obstructive sleep apnea in adults with obesity in December 2024. Some Express Scripts plans that exclude weight-loss drugs may still review Zepbound under the OSA indication. The prior authorization needs a sleep study, an AHI score, an obesity diagnosis, and clear documentation that the prescription is for OSA, not weight management.
This is one of the most overlooked coverage pathways for Zepbound. Plans that “exclude anti-obesity drugs” sometimes still cover the exact same medication when the indication on the chart says something different.
What to ask your doctor and Express Scripts
Ask Express Scripts:
“Is this Zepbound request being reviewed for chronic weight management, for moderate-to-severe OSA in an adult with obesity, or both?”
Ask your doctor:
“If I have a documented sleep study with an AHI of 15 or higher and an obesity diagnosis, can we submit the PA for the FDA-approved OSA indication?”
What the PA packet needs for OSA
- Sleep study results (in-lab polysomnography preferred, home sleep test sometimes accepted)
- AHI score (apnea-hypopnea index)
- Obesity diagnosis
- Current and baseline BMI
- Prior OSA treatment history (CPAP attempts, intolerance documentation)
- Statement linking Zepbound to FDA-labeled OSA use
We’re not going to tell you OSA is a magic bypass. Many plans still apply weight-management criteria even when the indication is OSA. For people who actually have OSA and have struggled with CPAP, this is a path worth asking about — and most other “does Express Scripts cover Zepbound” articles don’t mention it at all.
Does Express Scripts Medicare Cover Zepbound?
Short answer
For weight-management use, most Medicare Part D coverage paths still don’t cover anti-obesity medications through normal Part D benefits. But Zepbound has two separate Medicare-relevant paths: OSA review under Part D, and the Medicare GLP-1 Bridge for qualifying weight-management use from July 1, 2026 through December 31, 2027. The Bridge covers Zepbound KwikPen only (not single-dose vial or single-dose pen) at a $50 copay for eligible beneficiaries.
Anyone who tells you “Medicare never covers Zepbound, end of story” is reading off a 2024 script. Two updates have changed that.
The OSA pathway under Medicare Part D
Because Zepbound’s FDA label now includes obstructive sleep apnea in adults with obesity, some Medicare Part D plans may evaluate Zepbound under the OSA indication — a basic Part D-coverable medical use, not a weight-management use. This isn’t universal. It depends on your specific Part D plan’s formulary and how its utilization management team interprets the label. Ask your plan directly. Bring your sleep study.
The Medicare GLP-1 Bridge (July 1, 2026 – December 31, 2027)
Per CMS, the Bridge is a temporary federal program designed to give qualifying Medicare beneficiaries access to GLP-1 medications for weight management while CMS develops the longer-term BALANCE Model (starting January 2027 in Part D). The Bridge operates outside the normal Part D payment flow.
| Program window | July 1, 2026 through December 31, 2027 |
| Eligible Zepbound product | Zepbound KwikPen only. Single-dose vials and single-dose pens are NOT available through the Bridge. |
| Copay | $50/month at the pharmacy for eligible beneficiaries |
| TrOOP impact | The $50 Bridge copay does NOT count toward your Part D true out-of-pocket (TrOOP) costs |
Bridge eligibility criteria (per CMS)
Lifestyle modification, plus one of the following:
- BMI ≥35, OR
- BMI ≥30 with HFpEF (heart failure with preserved ejection fraction), uncontrolled hypertension, or chronic kidney disease stage 3a or higher, OR
- BMI ≥27 with prediabetes, previous myocardial infarction, previous stroke, or symptomatic peripheral arterial disease
Until July 1 — lowest verified self-pay path for Medicare beneficiaries
Medicare beneficiaries are excluded from the commercial Lilly savings card, but the LillyDirect Self Pay Journey Program is open to anyone paying cash with a valid US prescription. Pricing: $299/month (2.5 mg vial), $399/month (5 mg vial), $449/month (7.5–15 mg vial or KwikPen) when refilled within 45 days.
If you’re on Express Scripts Medicare and you’ve been told “Zepbound isn’t covered,” that may be technically true today and may change on July 1, 2026 for weight-management use. Get on your doctor’s calendar before then so the PA is ready to submit on day one.
Does TRICARE Through Express Scripts Cover Zepbound?
Short answer
Yes for most TRICARE Prime and TRICARE Select plan families with an approved prior authorization. TRICARE no longer covers weight-loss drugs for TRICARE For Life beneficiaries, beneficiaries only eligible for care at military hospitals or clinics, and NATO/Partnership for Peace beneficiaries.
| TRICARE situation | Zepbound coverage |
|---|---|
| TRICARE Prime, Prime Remote, Prime Overseas, Young Adult-Prime | Covered with approved PA |
| TRICARE Select, Select Overseas, Reserve Select, Retired Reserve, Young Adult-Select | Covered with approved PA |
| Continued Health Care Benefit Program (CHCBP) | Covered with approved PA |
| TRICARE For Life | Not covered for weight loss |
| Beneficiaries only eligible for care at MTFs (military hospitals/clinics) | Not covered for weight loss |
| NATO and Partnership for Peace beneficiaries | Not covered for weight loss |
| Required prescriber | TRICARE-authorized provider |
| Required pharmacy | TRICARE network pharmacy |
If you’re in a covered TRICARE plan family, the path is identical to commercial Express Scripts: confirm coverage, get the PA submitted with full documentation, fill at a network pharmacy. Our TRICARE GLP-1 coverage guide walks through PA criteria for TRICARE specifically.
What to Do If Express Scripts Denied Your Zepbound Prior Authorization
Short answer
A denial is not always the end. The denial letter controls the next move: resubmission, formal appeal, formulary exception request, indication-specific review, switching to a covered alternative, or pivoting to cash-pay. Appeal deadlines vary by plan type and are printed in your denial letter — for Medicare drug plans, redeterminations must generally be requested within 65 days from the date on the initial denial notice.
The six most common denial reasons and the fix for each
| Denial reason | What it really means | Your move |
|---|---|---|
| "Information provided did not contain sufficient information to determine medical necessity" | Doctor didn't send enough documentation | Resubmit with current BMI, comorbidity codes, weight-management history |
| Step therapy not satisfied | Plan wants you to try a preferred alternative first (often Wegovy, liraglutide, or phentermine) | Document the trial-and-failure, or document a contraindication |
| Plan exclusion of weight-loss drugs | Your plan doesn't cover anti-obesity meds | A standard PA may not fix it. Ask whether your plan allows a formulary exception or indication-specific review; if not, pivot to OSA review (if medically relevant), LillyDirect/self-pay, or a brand-name telehealth path |
| Wrong formulation | Doctor wrote for vials on a plan that excludes vials | Have the doctor rewrite for Zepbound Pen |
| Renewal expired or plan changed | Previous approval ended, or your plan renegotiated the benefit | Submit a renewal PA with current weight data showing continued benefit |
| Lifestyle program engagement missing | Plan requires Omada Health, Teladoc Health, or similar engagement | Enroll, complete required engagement, resubmit |
What to look for in your denial letter
Before you appeal, find these five items in the letter. Write them down on the same page.
- Drug name and exact formulation denied (Zepbound, Zepbound Pen, Zepbound Vial, KwikPen)
- Specific denial reason — usually one line, sometimes buried in the second paragraph
- Specific criteria the plan says you didn’t meet
- Appeal deadline and the exact submission method (fax number, portal URL)
- Whether the denial is pharmacy benefit, medical benefit, or Medicare Bridge related
A one-week denial can be a paperwork problem, but don’t guess. Read the denial reason first. If it says missing information, have your doctor resubmit a complete PA packet before filing a formal appeal — resubmission is usually faster than appeal.
What goes in the Letter of Medical Necessity
This is the doctor’s letter, but you may have to push your doctor to write a thorough one. The strongest LMNs include:
- Your full diagnosis with ICD-10 code
- Current BMI plus baseline BMI when treatment started
- All weight-related comorbidities with diagnosis dates
- Documented prior weight-management attempts (diet programs, exercise plans, prior medications and why they failed or weren’t tolerated)
- Why Zepbound specifically is the appropriate next step
- Clinical evidence from FDA-labeled trial data (the SURMOUNT-1 outcomes show meaningful average weight reduction over 72 weeks at higher doses)
- An explicit statement: “Zepbound is medically necessary for this patient.”
Our GLP-1 Medical Necessity Letter guide has a fill-in-the-blanks LMN your doctor can adapt.
Denied and not sure whether to appeal, switch formulations, or pivot to cash-pay?
Answer four questions about your situation and we’ll match you to the cleanest next step — appeal, OSA pathway, savings card, LillyDirect, or a telehealth provider that handles PA paperwork.
What If Your Express Scripts Plan Flat-Out Excludes Zepbound?
Short answer
A standard PA or LMN may not fix a hard plan exclusion. Two legal alternatives keep you on brand-name FDA-approved tirzepatide. LillyDirect’s Self Pay Journey Program ships Zepbound single-dose vials directly from Eli Lilly’s pharmacy partners. Branded Zepbound through Ro Body provides a telehealth-managed prescription plus the insurance concierge in case you want one more shot at coverage on a future plan.
Some plans exclude all anti-obesity medications. No standard PA or LMN is going to fix that — the exclusion is in the plan document itself, written by your employer or plan sponsor. Ask whether your plan allows a formulary exception or indication-specific review. If you’re medically eligible for OSA review, that’s the cleanest path back into coverage. If it doesn’t, time to pivot.
LillyDirect Self Pay Journey Program
Lowest verified manufacturer self-pay path for brand-name FDA-approved Zepbound vials. Non-affiliate link.
- Cannot be combined with insurance
- Medicare/Medicaid beneficiaries can use LillyDirect as cash-pay
- Miss the 45-day refill window and price reverts — set a calendar reminder around day 30
Branded Zepbound through Ro Body
When you want telehealth, a clean prescription pipeline, and a real shot at getting insurance to pay later.
- Carries Zepbound Pen, Zepbound KwikPen, Wegovy pill & pen, Foundayo
- Dedicated insurance concierge for enrolled members on supported plans
- Free GLP-1 Insurance Coverage Checker for anyone
Disclosure: The RX Index may earn a commission from Ro links.
See Ro Body’s Zepbound pricing →Honest trade-off
If you don’t need insurance help and you have a doctor who’ll write the prescription, LillyDirect direct is cheaper — no membership fee. Ro’s $149/month standard membership is an extra cost LillyDirect doesn’t charge. Ro is worth it when paperwork is the problem. LillyDirect is worth it when you just want the drug at the lowest possible price.
A quick note: compounded tirzepatide is not the same as FDA-approved Zepbound. It’s made by compounding pharmacies under different regulatory rules. If you want to explore that path, do it on a page built for that decision — our branded Zepbound provider comparison lays out the differences clearly.
Real Searcher Friction — What People Are Running Into
Pulled from public Reddit threads on r/Zepbound. Used as friction examples, not as evidence of coverage rules.
The lifestyle-program surprise
"I just received the following letter in the mail from Express Scripts…"
That letter probably announced a 2026 Omada or Teladoc enrollment requirement. Several major employer plans (NYC Carpenters Welfare Fund, the Foreign Service Benefit Plan, and others) added one for the 2026 plan year. If you got the letter, you have to enroll, hit the engagement requirements, AND have your doctor submit a NEW prior authorization. Old PAs don't always carry over.
The EnGuide confusion
"I'm confused, when I get to 10mg where do I go?"
That's an EnGuide question, not a coverage problem. If your plan uses EnGuide Pharmacy for GLP-1 home delivery, your higher doses might route through EnGuide instead of your usual mail order or retail pharmacy. Ask Express Scripts to confirm the pharmacy channel for your dose.
The denial after one week
"My doctor wrote in the prescription for Zepbound and after a week, I got the notification from Express Scripts that my PA was denied."
A fast denial can be a paperwork problem. Read the letter first. If it says missing information, have your doctor resubmit a complete PA packet — resubmission is usually faster than appeal.
Frequently Asked Questions About Express Scripts and Zepbound
Does Express Scripts cover Zepbound for weight loss?
Sometimes. The 2026 Express Scripts National Preferred Formulary lists ZEPBOUND PEN [INJ], but each employer or plan sponsor decides whether their specific plan includes anti-obesity drug coverage. Many plans exclude weight-loss medications entirely even when Express Scripts has Zepbound on its default formulary.
Is Zepbound on the Express Scripts formulary in 2026?
Yes — Zepbound Pen is on the 2026 National Preferred Formulary. Zepbound Vials are on the 2026 NPF Exclusions list, with Zepbound Pens, Wegovy injection, Wegovy tablets, and liraglutide named as the preferred alternatives.
Are Zepbound vials covered by Express Scripts?
On the default 2026 National Preferred Formulary, no — vials are listed as excluded. Some custom plans may differ, but expect to be moved to Zepbound Pen or one of the named alternatives.
Does Express Scripts require prior authorization for Zepbound?
Many Express Scripts-administered plans do. The requirement is plan-specific. PA criteria commonly align with Zepbound's FDA label: adults with obesity (BMI ≥30) or adults with overweight (BMI ≥27) and at least one weight-related comorbidity. Use your denial letter or PA form as the source of truth for your plan.
How long does Express Scripts Zepbound prior authorization take?
Express Scripts says nearly all coverage reviews are completed within two days after the doctor sends complete information. In practice it often runs 2–3 weeks because of paperwork going back and forth.
Can I use the Lilly Zepbound Savings Card with Express Scripts?
Yes, if you have commercial Express Scripts coverage and your plan covers Zepbound. The card cannot be used with Medicare, Medicaid, TRICARE, VA, or other government insurance. The 2026 caps are $100/fill (1-month) and $1,300/year. The card expires December 31, 2026.
How much does Zepbound cost with Express Scripts?
With the Lilly savings card on a covered commercial plan: as low as $25/fill (up to plan-specific limits). On plans participating in the $200 affordability arrangement: up to $200/month. Without coverage: $299–$449/month through LillyDirect Self Pay vials.
What is EncircleRx and how does it affect my Zepbound coverage?
EncircleRx is Evernorth's GLP-1 financial management program for plan sponsors. If your plan uses EncircleRx, your access may be tied to engaging with a lifestyle coaching program. The specific program (Omada, Teladoc, or another) varies by plan.
What is EnGuide Pharmacy?
EnGuide is Evernorth's home delivery pharmacy focused on GLP-1 dispensing. If your plan uses EnGuide, your Zepbound may have to fill there for home delivery instead of through a retail pharmacy or your usual mail-order pharmacy.
Will Express Scripts drop Zepbound like CVS Caremark did?
No announcement as of May 2026. CVS Caremark excluded Zepbound from its standard formulary effective July 1, 2025. Express Scripts has kept Zepbound Pen on its 2026 National Preferred Formulary. We watch for announcements at each open enrollment cycle.
Does Express Scripts Medicare cover Zepbound?
For weight management, most Medicare Part D coverage paths don't cover anti-obesity medications. Two exceptions: Zepbound for FDA-approved OSA in adults with obesity may be reviewable under Part D, and the Medicare GLP-1 Bridge (July 1, 2026 – Dec 31, 2027) covers Zepbound KwikPen only at a $50 copay for qualifying beneficiaries. The $50 Bridge copay does not count toward TrOOP.
Does TRICARE through Express Scripts cover Zepbound?
Yes for most TRICARE Prime and TRICARE Select plan families with an approved prior authorization. TRICARE For Life beneficiaries, MTF-only beneficiaries, and NATO/Partnership for Peace beneficiaries are no longer covered for weight-loss drugs.
What if my Express Scripts plan flat-out excludes Zepbound for weight loss?
Ask whether your plan allows a formulary exception or indication-specific review. If you have OSA, ask about review under the OSA indication. If neither works, two legal options remain: LillyDirect Self Pay ($299–$449/month) or branded Zepbound through a telehealth provider like Ro.
What's the difference between Mounjaro and Zepbound for Express Scripts coverage?
Both contain tirzepatide, but they're different brand-name drugs with different FDA-approved indications — Mounjaro for type 2 diabetes; Zepbound for chronic weight management and OSA. Coverage rules are completely separate. Don't assume a Mounjaro result predicts a Zepbound result.
Still Not Sure Which GLP-1 Program Is Right for You?
Most readers walk away with one of three answers:
My plan covers it.
Activate the Lilly Zepbound Savings Card, confirm the PA is submitted, and you’re done.
My plan needs a fight.
You’ll get cleaner results with a doctor who handles the paperwork.
Disclosure: The RX Index may earn a commission from Ro links.
See if Ro can submit your Express Scripts PA →My plan doesn’t cover it.
Compare your two best legal cash-pay paths — LillyDirect direct, or branded Zepbound through telehealth.
Not sure which one you are?
Take our free 60-second GLP-1 matching quiz. Four questions, one personalized action plan, no email gate.
Take the free GLP-1 path quiz →Related Guides
Sources Cited on This Page
- Express Scripts. 2026 National Preferred Formulary (PDF). express-scripts.com.
- Express Scripts. 2026 National Preferred Formulary Exclusions (PDF). express-scripts.com.
- Express Scripts. Coverage Reviews / Prior Authorization FAQ. express-scripts.com.
- Evernorth. Prior Authorization Resources. evernorth.com.
- Evernorth. Express Scripts expands Patient Assurance Program to drive affordability and access to GLP-1s.
- Eli Lilly and Company. Zepbound Self Pay Journey Program Purchase Offer Full Terms. lilly.com/lillydirect.
- Eli Lilly and Company. Zepbound Savings Card terms. zepbound.lilly.com/savings.
- Eli Lilly and Company. Zepbound Cost Information. pricinginfo.lilly.com/zepbound.
- U.S. Food and Drug Administration. Zepbound (tirzepatide) Prescribing Information. accessdata.fda.gov.
- Centers for Medicare & Medicaid Services. Medicare GLP-1 Bridge. cms.gov.
- Medicare.gov. Appeals in a Medicare drug plan.
- TRICARE. Weight Loss Products. tricare.mil.
- militaryrx.express-scripts.com. GLP-1 Medications (Diabetes and Weight Management).
- AFSPA. GLP-1 FAQs. afspa.org.
- NYCDCC Benefit Funds. Express Scripts Announces Changes for Participants Prescribed GLP-1s for Weight Loss: Effective January 1, 2026.
- Ro. Pricing and GLP-1 Insurance Coverage Checker. ro.co.
- Reddit r/Zepbound. Public threads cited as voice-of-customer friction examples only, not as evidence of coverage rules.
About This Page
The RX Index is a pricing intelligence and comparison resource for GLP-1 telehealth providers. We built this page because every existing “does Express Scripts cover Zepbound” article we found stopped at “it depends on your employer.” That’s true — and useless on its own. Our job is to make “it depends” actionable: tell you exactly what to check, give you the script to find out, decode the programs your plan might be in, and route you to the right next step depending on the answer.
We update this page on a fixed cadence. Pricing and savings-card terms are checked monthly. Formulary status and PA criteria are checked quarterly. Major changes (a PBM exclusion announcement, a federal program launch, a Lilly price change) trigger an immediate update.
Editorial standards: Every commercial fact is sourced to a publicly verifiable primary source. Medical and regulatory facts are sourced to FDA labeling, peer-reviewed literature, or government documents.
This page does not provide medical advice. Always talk to a qualified healthcare provider before starting, stopping, or changing any medication.